20172-Urothelial Cancer-NA-1519

Urothelial Cancer

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Address

1105 Central Expressway, Suite 320
Allen, TX 75013
P: (469) 467-4392

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.